2024. CRISPR Base Editing for a Monogenic Liver Disorder: Off-Target Assessment and Long-Term Follow-Up Obligations. Translational Medicine & Therapeutics Journal. 3, 2 (Aug. 2024), 74–82. DOI:https://doi.org/10.5281/zenodo.22649285.